Skip to main content
. Author manuscript; available in PMC: 2014 Sep 1.
Published in final edited form as: J Diabetes. 2013 May 29;5(3):327–335. doi: 10.1111/1753-0407.12014

Table 1.

Description of Sample Characteristics by Antidepressant Use Medicare Current Beneficiary Survey, 2001–2005

Total Sample Antidepressant Use
No Short-term Long-Term Sig
N Wt % Wt% Wt% W%
ALL 10,134 100.0 81.5 10.3 8.3
General Health ***
  Excellent 1,954 20.2 89.4 6.7 3.9
  Very good 3,226 32.8 84.8 8.9 6.2
  Good 3,230 31.3 80.8 10.3 8.9
  Fair 1,336 12.4 68.7 15.9 15.3
  Poor 349 3.2 53.6 24.1 22.3
Functional Status: ADL a ***
  Not limited 7,719 78.7 84.6 8.8 6.6
  1–2 1,739 15.7 72.1 14.5 13.4
  3 and above 667 5.6 63.5 19.3 17.2
Body Mass Index Category **
  Under/Normal 4,540 43.5 81.1 11.1 7.7
  Overweight 3,951 39.8 82.7 9.2 8.1
  Obesity 1,578 16.7 79.2 10.7 10.1
Smoking Status
  Current smoker 1,116 11.8 79.4 12.1 8.5
  Past smoker 4,761 47.2 82.1 9.7 8.2
  Never smoked 4,243 41.0 81.4 10.4 8.2
Hypertension ***
  No 4,701 47.6 84.3 9.3 6.3
  Yes 5,433 52.4 78.8 11.1 10.1
Depression ***
  No 9,191 91.1 86.4 8.2 5.4
  Yes 625 5.8 31.4 30.9 37.6

Note: Analytic sample consists of Medicare beneficiaries who were followed for 3-years and were first interviewed either in 1999, or 2000 or,2001 or 2002 or 2003, lived in the community.

Asterisks represent significant group differences between antidepressant use and subject characteristics based on chi-square tests. Long-term use represents antidepressant prescriptions reported for all 3-years; short-term use represents antidepressant prescriptions reported in one or two years.

a

ADL: Activities of daily living;

Wt: Weighted. HS: High School

***

p < .001;

**

.001 ≤ p < .01;

*

.01 ≤ p < .05